Sitagliptin inhibits EndMT in vitro and improves cardiac function of diabetic rats through the SDF-1α/PKA pathway
European Review for Medical and Pharmacological Sciences (2019) - Comments
pubmed: 30720193  doi: 10.26355/eurrev_201901_16899  issn: 1128-3602  issn: 2284-0729 

Y. Wu, M. Xu, H. Bao, J.-H. Zhang